Report Detail

Pharma & Healthcare Global Veterinary Drugs for Companion Animals Market Growth (Status and Outlook) 2022-2028

  • RnM4488440
  • |
  • 30 August, 2022
  • |
  • Global
  • |
  • 103 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

The global market for Veterinary Drugs for Companion Animals is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Veterinary Drugs for Companion Animals market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Veterinary Drugs for Companion Animals market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Veterinary Drugs for Companion Animals market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Veterinary Drugs for Companion Animals market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Veterinary Drugs for Companion Animals players cover Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health and Bayer Animal Health, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Veterinary Drugs for Companion Animals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Veterinary Drugs for Companion Animals market, with both quantitative and qualitative data, to help readers understand how the Veterinary Drugs for Companion Animals market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Veterinary Drugs for Companion Animals market and forecasts the market size by Type (Injection and Taking Class,), by Application (Farm, Veterinary Clinic and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Injection
Taking Class

Segmentation by application
Farm
Veterinary Clinic
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Bayer Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell

Chapter Introduction
Chapter 1: Scope of Veterinary Drugs for Companion Animals, Research Methodology, etc.
Chapter 2: Executive Summary, global Veterinary Drugs for Companion Animals market size and CAGR, Veterinary Drugs for Companion Animals market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Veterinary Drugs for Companion Animals revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Veterinary Drugs for Companion Animals revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Veterinary Drugs for Companion Animals market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Bayer Animal Health, Virbac, Dechra Veterinary Products, Ceva and Vetoquinol, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Veterinary Drugs for Companion Animals Market Size 2017-2028
    • 2.1.2 Veterinary Drugs for Companion Animals Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Veterinary Drugs for Companion Animals Segment by Type
    • 2.2.1 Injection
    • 2.2.2 Taking Class
  • 2.3 Veterinary Drugs for Companion Animals Market Size by Type
    • 2.3.1 Veterinary Drugs for Companion Animals Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Veterinary Drugs for Companion Animals Market Size Market Share by Type (2017-2022)
  • 2.4 Veterinary Drugs for Companion Animals Segment by Application
    • 2.4.1 Farm
    • 2.4.2 Veterinary Clinic
    • 2.4.3 Others
  • 2.5 Veterinary Drugs for Companion Animals Market Size by Application
    • 2.5.1 Veterinary Drugs for Companion Animals Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Veterinary Drugs for Companion Animals Market Size Market Share by Application (2017-2022)

3 Veterinary Drugs for Companion Animals Market Size by Player

  • 3.1 Veterinary Drugs for Companion Animals Market Size Market Share by Players
    • 3.1.1 Global Veterinary Drugs for Companion Animals Revenue by Players (2020-2022)
    • 3.1.2 Global Veterinary Drugs for Companion Animals Revenue Market Share by Players (2020-2022)
  • 3.2 Global Veterinary Drugs for Companion Animals Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Veterinary Drugs for Companion Animals by Regions

  • 4.1 Veterinary Drugs for Companion Animals Market Size by Regions (2017-2022)
  • 4.2 Americas Veterinary Drugs for Companion Animals Market Size Growth (2017-2022)
  • 4.3 APAC Veterinary Drugs for Companion Animals Market Size Growth (2017-2022)
  • 4.4 Europe Veterinary Drugs for Companion Animals Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Veterinary Drugs for Companion Animals Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Veterinary Drugs for Companion Animals Market Size by Country (2017-2022)
  • 5.2 Americas Veterinary Drugs for Companion Animals Market Size by Type (2017-2022)
  • 5.3 Americas Veterinary Drugs for Companion Animals Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Veterinary Drugs for Companion Animals Market Size by Region (2017-2022)
  • 6.2 APAC Veterinary Drugs for Companion Animals Market Size by Type (2017-2022)
  • 6.3 APAC Veterinary Drugs for Companion Animals Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Veterinary Drugs for Companion Animals by Country (2017-2022)
  • 7.2 Europe Veterinary Drugs for Companion Animals Market Size by Type (2017-2022)
  • 7.3 Europe Veterinary Drugs for Companion Animals Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Veterinary Drugs for Companion Animals by Region (2017-2022)
  • 8.2 Middle East & Africa Veterinary Drugs for Companion Animals Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Veterinary Drugs for Companion Animals Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Veterinary Drugs for Companion Animals Market Forecast

  • 10.1 Global Veterinary Drugs for Companion Animals Forecast by Regions (2023-2028)
    • 10.1.1 Global Veterinary Drugs for Companion Animals Forecast by Regions (2023-2028)
    • 10.1.2 Americas Veterinary Drugs for Companion Animals Forecast
    • 10.1.3 APAC Veterinary Drugs for Companion Animals Forecast
    • 10.1.4 Europe Veterinary Drugs for Companion Animals Forecast
    • 10.1.5 Middle East & Africa Veterinary Drugs for Companion Animals Forecast
  • 10.2 Americas Veterinary Drugs for Companion Animals Forecast by Country (2023-2028)
    • 10.2.1 United States Veterinary Drugs for Companion Animals Market Forecast
    • 10.2.2 Canada Veterinary Drugs for Companion Animals Market Forecast
    • 10.2.3 Mexico Veterinary Drugs for Companion Animals Market Forecast
    • 10.2.4 Brazil Veterinary Drugs for Companion Animals Market Forecast
  • 10.3 APAC Veterinary Drugs for Companion Animals Forecast by Region (2023-2028)
    • 10.3.1 China Veterinary Drugs for Companion Animals Market Forecast
    • 10.3.2 Japan Veterinary Drugs for Companion Animals Market Forecast
    • 10.3.3 Korea Veterinary Drugs for Companion Animals Market Forecast
    • 10.3.4 Southeast Asia Veterinary Drugs for Companion Animals Market Forecast
    • 10.3.5 India Veterinary Drugs for Companion Animals Market Forecast
    • 10.3.6 Australia Veterinary Drugs for Companion Animals Market Forecast
  • 10.4 Europe Veterinary Drugs for Companion Animals Forecast by Country (2023-2028)
    • 10.4.1 Germany Veterinary Drugs for Companion Animals Market Forecast
    • 10.4.2 France Veterinary Drugs for Companion Animals Market Forecast
    • 10.4.3 UK Veterinary Drugs for Companion Animals Market Forecast
    • 10.4.4 Italy Veterinary Drugs for Companion Animals Market Forecast
    • 10.4.5 Russia Veterinary Drugs for Companion Animals Market Forecast
  • 10.5 Middle East & Africa Veterinary Drugs for Companion Animals Forecast by Region (2023-2028)
    • 10.5.1 Egypt Veterinary Drugs for Companion Animals Market Forecast
    • 10.5.2 South Africa Veterinary Drugs for Companion Animals Market Forecast
    • 10.5.3 Israel Veterinary Drugs for Companion Animals Market Forecast
    • 10.5.4 Turkey Veterinary Drugs for Companion Animals Market Forecast
    • 10.5.5 GCC Countries Veterinary Drugs for Companion Animals Market Forecast
  • 10.6 Global Veterinary Drugs for Companion Animals Forecast by Type (2023-2028)
  • 10.7 Global Veterinary Drugs for Companion Animals Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Zoetis
    • 11.1.1 Zoetis Company Information
    • 11.1.2 Zoetis Veterinary Drugs for Companion Animals Product Offered
    • 11.1.3 Zoetis Veterinary Drugs for Companion Animals Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Zoetis Main Business Overview
    • 11.1.5 Zoetis Latest Developments
  • 11.2 Boehringer Ingelheim
    • 11.2.1 Boehringer Ingelheim Company Information
    • 11.2.2 Boehringer Ingelheim Veterinary Drugs for Companion Animals Product Offered
    • 11.2.3 Boehringer Ingelheim Veterinary Drugs for Companion Animals Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Boehringer Ingelheim Main Business Overview
    • 11.2.5 Boehringer Ingelheim Latest Developments
  • 11.3 Merck Animal Health
    • 11.3.1 Merck Animal Health Company Information
    • 11.3.2 Merck Animal Health Veterinary Drugs for Companion Animals Product Offered
    • 11.3.3 Merck Animal Health Veterinary Drugs for Companion Animals Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Merck Animal Health Main Business Overview
    • 11.3.5 Merck Animal Health Latest Developments
  • 11.4 Elanco Animal Health
    • 11.4.1 Elanco Animal Health Company Information
    • 11.4.2 Elanco Animal Health Veterinary Drugs for Companion Animals Product Offered
    • 11.4.3 Elanco Animal Health Veterinary Drugs for Companion Animals Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Elanco Animal Health Main Business Overview
    • 11.4.5 Elanco Animal Health Latest Developments
  • 11.5 Bayer Animal Health
    • 11.5.1 Bayer Animal Health Company Information
    • 11.5.2 Bayer Animal Health Veterinary Drugs for Companion Animals Product Offered
    • 11.5.3 Bayer Animal Health Veterinary Drugs for Companion Animals Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Bayer Animal Health Main Business Overview
    • 11.5.5 Bayer Animal Health Latest Developments
  • 11.6 Virbac
    • 11.6.1 Virbac Company Information
    • 11.6.2 Virbac Veterinary Drugs for Companion Animals Product Offered
    • 11.6.3 Virbac Veterinary Drugs for Companion Animals Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Virbac Main Business Overview
    • 11.6.5 Virbac Latest Developments
  • 11.7 Dechra Veterinary Products
    • 11.7.1 Dechra Veterinary Products Company Information
    • 11.7.2 Dechra Veterinary Products Veterinary Drugs for Companion Animals Product Offered
    • 11.7.3 Dechra Veterinary Products Veterinary Drugs for Companion Animals Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Dechra Veterinary Products Main Business Overview
    • 11.7.5 Dechra Veterinary Products Latest Developments
  • 11.8 Ceva
    • 11.8.1 Ceva Company Information
    • 11.8.2 Ceva Veterinary Drugs for Companion Animals Product Offered
    • 11.8.3 Ceva Veterinary Drugs for Companion Animals Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Ceva Main Business Overview
    • 11.8.5 Ceva Latest Developments
  • 11.9 Vetoquinol
    • 11.9.1 Vetoquinol Company Information
    • 11.9.2 Vetoquinol Veterinary Drugs for Companion Animals Product Offered
    • 11.9.3 Vetoquinol Veterinary Drugs for Companion Animals Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Vetoquinol Main Business Overview
    • 11.9.5 Vetoquinol Latest Developments
  • 11.10 Meiji
    • 11.10.1 Meiji Company Information
    • 11.10.2 Meiji Veterinary Drugs for Companion Animals Product Offered
    • 11.10.3 Meiji Veterinary Drugs for Companion Animals Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Meiji Main Business Overview
    • 11.10.5 Meiji Latest Developments
  • 11.11 Ouro Fino Saude
    • 11.11.1 Ouro Fino Saude Company Information
    • 11.11.2 Ouro Fino Saude Veterinary Drugs for Companion Animals Product Offered
    • 11.11.3 Ouro Fino Saude Veterinary Drugs for Companion Animals Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Ouro Fino Saude Main Business Overview
    • 11.11.5 Ouro Fino Saude Latest Developments
  • 11.12 Parnell
    • 11.12.1 Parnell Company Information
    • 11.12.2 Parnell Veterinary Drugs for Companion Animals Product Offered
    • 11.12.3 Parnell Veterinary Drugs for Companion Animals Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Parnell Main Business Overview
    • 11.12.5 Parnell Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Veterinary Drugs for Companion Animals. Industry analysis & Market Report on Veterinary Drugs for Companion Animals is a syndicated market report, published as Global Veterinary Drugs for Companion Animals Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Veterinary Drugs for Companion Animals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,407.46
6,814.92
3,806.40
7,612.80
528,321.00
1,056,642.00
298,326.60
596,653.20
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report